bioRxivImmunologyPreprint
Mapping the MIF-2 Chemokine Interactome Reveals MIF-2-CCL20 Complex Formation in Liver Fibrosis
Adrian HoffmanniD, Markus BrandhoferiD, Yufei HeiD, Genta Bushati, Elena Siminkovitch, Xavier BlanchetiD, Michael K. Otabil, Lin ZhangiD, Simon EbertiD, Mathias Holzner, Christine Krammer, Kathleen Hille, Christian Werner WichmanniD, Hanno NießiD, Omar El BounkariiD, Christian WeberiD, Aphrodite KapurniotuiD, Philipp von HundelshauseniD, Patrick ScheiermanniD, Jürgen BernhageniD
Abstract
D-dopachrome tautomerase (D-DT/MIF-2) is an inflammatory cytokine, atypical chemokine (ACK) and member of the macrophage migration-inhibitory factor (MIF) family. While interactions among classical chemokines (CKs) are established, ACK-CK interactions remain underexplored. Here, we screened for MIF-2 binding-partners using a protein array encompassing all CKs and selected ACKs, and validated candidate interactors by surface-plasmon resonance. CCL20/MIP-3 was prioritized based on RNA-sequencing suggesting induction during liver fibrosis. MIF-2/CCL20 complex formation was verified by microscale thermophoresis and interaction interfaces mapped using peptide array and in-silico modeling. The deduced binding-site near the MIF-2 tautomerase pocket was consistent with inhibition of its tautomerase activity by CCL20. We found both proteins abundantly expressed in human liver tissue, with a positive correlation. Pull-down confirmed complex formation and proximity ligation assay demonstrated MIF-2/CCL20 complexes in liver in situ, with higher levels in fibrotic tissue. Functionally, MIF-2/CCL20 complexes suppressed MIF-2-driven CD4 T-cell chemotaxis and fibroblast IL-6 secretion, indicating modulation of immune and stromal responses. This study extends the ACK interactome to MIF-2 and suggests ACK/CK complexes modulate chemokine activities in liver fibrosis.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Heterocomplexes between the Atypical Chemokine MIF and the CXC-Motif Chemokine CXCL4L1 Regulate Inflammation and Thrombus Formation
M. Brandhofer, A. Hoffmann, … J. Bernhagen·bioRxiv·Nov 26, 2021
- MIF-2/D-DT is an atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis
O. El Bounkari, C. Zan, … J. Bernhagen·bioRxiv·Dec 28, 2021
- Identification, Purification and Characterization of Mast Cells in Murine Liver Fibrosis: Novel Methods, Expression Signatures and Correlation with Disease Severity
Christian Penners, Julia Otto, … Christian Liedtke·Frontiers in ImmunologyPeer-reviewed·Jul 14, 2026
- Cannabinoid Receptor 2 Activating Antibodies: A Promising Therapeutic Strategy for Macrophage-Driven Fibro-Inflammatory Diseases
Raghavender Reddy Gopireddy, Dipankar Bhattacharya, … Lauren J. Schwimmer·Molecular PharmacologyPeer-reviewed·Jan 14, 2026
- CXCL8/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosis
A. Dunbar, D. Kim, … R. Hoffman·bioRxiv·Dec 8, 2021
- Expression of the Close homolog of L-1 and embigin identifies activated myofibroblasts.
Angus T. Stock, Jess Day, … Ian P. Wicks·bioRxiv·Feb 24, 2025